Raily Aesthetic Medicine International Holdings Limited (HK:2135) has released an update.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Raily Aesthetic Medicine International Holdings Limited has announced a strategic acquisition deal with Suneva, securing exclusive distribution rights for Bellafill in Greater China and an equity interest. The company will pay a total of USD5 million for distribution rights and USD500,000 for equity, highlighting its ambitious plans to expand in the medical aesthetics market. This move positions Raily Aesthetic Medicine to capitalize on lucrative opportunities in the region.
For further insights into HK:2135 stock, check out TipRanks’ Stock Analysis page.